摘要
抗血小板药物在动脉粥样硬化导致的血栓事件一级预防和二级预防中发挥着重要的作用。但是与降压药、降糖药和降脂药不同,临床目前一般不根据抗血小板治疗的效果而调整抗血小板药物剂量。近年来,这种给予固定剂量的抗血小板药物而不常规监测血小板抑制程度的做法受到挑战。
出处
《检验医学》
CAS
2013年第5期442-447,共6页
Laboratory Medicine
参考文献16
-
1Angiolillo DJ. Variability in responsiveness to oral antiplatelet therapy [ J]. Am J Cardiol, 2009, 103 (3Suppl) : 27A-34A.
-
2Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity [ J ]. Eur HeartJ, 2006, 27(6) : 647-654.
-
3Snoep JD, Hovens MM, Eikenboom JC, et al. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis [ J ]. Arch Intern Med, 2007, 167(15) : 1593-1599.
-
4Soft F, Marcucci R, Gori AM, et al. Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events-a meta-analysis [ J ]. Int J Car- diol, 2008, 128(2): 166-171.
-
5Frelinger AL 3rd, Furman MI, Linden MD, et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclo- oxygenase-l-and cyclooxygenase-2-independent path- way : a 700-patient study of aspirin resistance [ J ]. Circulation, 2006, 113 ( 25 ) : 2888-2896.
-
6Michelson AD, Linden MD, Barnard MR, et al. Flow cytometry [ M ]. 2nd ed. SanDiego : Elsevier/ Academic Press, 2007:545-564.
-
7McEver RP. P-Selectin/PSGL-1 and other interactions between platelets, leukocytes, and endothelium[ M]. 2nd ed. San Diego: Elsevier/Academic Press, 2007: 231-249.
-
8饶绘,赵惠,李彬,润袁敏.PCI术前测定血小板表面P-选择素的意义[J].检验医学,2012,27(1):12-14. 被引量:6
-
9Cattaneo M. The platelet P2 receptors. In: Michelson AD, ed. Platelets [M]. 2nd ed. San Diego: Elsevi- er/Academic Press, 2007:201-220.
-
10Harrison P, Keeling D. Clinical tests of platelet func- tion [ M ]. 2nd ed. San Diego : Elsevier/Academic Press, 2007:445-474.
二级参考文献10
-
1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2149
-
2Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated pXatelets rapidly lose surface P-selectin but continue to circulate and function [ J ]. Proc Natl Acad Sci USA, 1996, 93(21) :11877-11882.
-
3Ferroni P, Martini F, Riondino S, et, al. Soluble P- selectin as a marker of in vivo platelet activation [ J ]. Clin Chim Acta, 2009,399(1-2) : 88-91.
-
4Fox SC, May JA, Shah A, et, al. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin [ J ]. Platelets, 2009,20 (4) :250-259.
-
5Kobusiak-Prokopowicz M, Kuliczkowski W, Karolko B, et al . Platelet aggregation and P-selectin levels during exercise treadmill test in patients with ischaemic heart disease [ J ]. Kardiol Pol, 2006,64 (10) :1094-1100.
-
6Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology [ J ]. Eur Heart J,2008,29 (23) :2909-2945.
-
7Curvers J ,de Wildt-Eggne J,Heeremans J ,et al. Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a muhicenter optimization and standardization effort [ J ]. Transfusion, 2008,48 (7) : 1439-1446.
-
8Cuisset T, Frere C, Quilici J, et al . High post- treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome [ J ]. J Thromb Haemost, 2006, 4 ( 3 ) :542-549.
-
9Yokoyama S, Ikeda H, Haramaki N, et al. Platelet P- selectin plays an important role in arterial thrombogenesis by forming large stable plateletleukocyte aggregates [ J ]. J Am Coll Cardiol, 2005, 45 (8) : 1280-1286.
-
10Hirsh J, Guyatt G, Albers GW, et al. Executive summary: American college of chest physicians evidence-based clinical practice guidelines ( 8th edition) [J]. CHEST, 200S,133(6 Suppl) :71S-109S.
共引文献5
-
1王秀华.P选择素的生物学特性及其临床应用研究进展[J].现代检验医学杂志,2013,28(6):6-8.
-
2李燕.血小板功能检测与临床应用[J].内蒙古中医药,2014,33(31):116-117. 被引量:3
-
3蔡玉婵,李智.血小板功能检测及其在多种疾病中的研究进展[J].检验医学,2015,30(1):72-75. 被引量:3
-
4肖智谦,龙运玲,彭湘南,李其旺.P-选择素水平对不稳定心绞痛患者MACE发生率的影响[J].广西医科大学学报,2018,35(5):693-695. 被引量:3
-
5肖智谦,龙运玲,彭湘南,李其旺.不稳定心绞痛患者血hsCRP、P选择素水平与近期预后关系[J].心血管病防治知识(学术版),2018,8(4):19-21. 被引量:2
同被引文献55
-
1张丽华,杜雪,何培源,蒋立新.P2Y_(12)受体拮抗剂最新研究进展[J].中华临床医师杂志(电子版),2012,6(19):6001-6003. 被引量:3
-
2董静懿,李培成.冠心病患者血小板CD62p及GpⅡb/Ⅲa的变化[J].检验医学,2005,20(3):189-191. 被引量:11
-
3黄智勇,曾国琼,谭旭东,林源泉.血小板激活与活动期发生溃疡性结肠炎的关系[J].中国基层医药,2006,13(3):386-387. 被引量:6
-
4FURIE B, FURIE BC. Mechanisms of thrombus formation[J]. N Engl J Med, 2008,359(9) : 938- 949.
-
5Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantative measurement methods[ S]. EP5-A2, CLSI, 2004.
-
6National Committee for Clinical Laboratory Standards. Preliminary evaluation of quantitative clinical laboratory methods[ S]. EP10-A2, NCCLS, 2002.
-
7National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative measurement procedures : a statistical approach approved[S]. EP6-A, NCCLS, 2003.
-
8STEINHUBL SR, MOLITERNO DJ. The role of the platelet in the pathogenesis of atherothrombosis [ J ]. Am J Cardiovasc Drugs, 2005, 5(6) : 399-408.
-
9HAUBELT H, ANDERS C, HELLSTERN P. Can platelet function tests predict the clinical eiffacy of aspirin [ J ]. Semin Thromb Hemost, 2005, 31 (4) : 404-410.
-
10HWANG SJ, JEONG YH, KIM IS, et al. The cytochrome 2C19 * 2 and * 3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective pereutaneous cornary intervention[J]. Thromb Res, 2011, 127 ( 1 ) : 23- 28.
引证文献7
-
1吴莎莎,蒋龙元.抗血小板药物研究进展及临床应用情况[J].岭南急诊医学杂志,2014,19(1):78-80.
-
2马萍,马巧红,刘志军,仇玉民,徐清斌.氯吡格雷对冠心病患者血清血管扩张刺激磷蛋白磷酸化水平的影响[J].天津医药,2014,42(11):1135-1137. 被引量:14
-
3李燕.血小板功能检测与临床应用[J].内蒙古中医药,2014,33(31):116-117. 被引量:3
-
4蔡玉婵,李智.血小板功能检测及其在多种疾病中的研究进展[J].检验医学,2015,30(1):72-75. 被引量:3
-
5蔡玉婵,赵旭鸿,韩平,陈昌明,李智.PL-11血小板分析仪检测血小板计数及聚集功能的性能评价[J].检验医学,2015,30(9):926-930. 被引量:9
-
6李昌将.血小板减少、血液中微粒的临床检验探析[J].中国实用医药,2015,10(33):89-90. 被引量:1
-
7陈慧敏,许大雪,王恩艳.老年冠状动脉粥样硬化性心脏病抗血小板药物治疗药物合理应用管理[J].中国卫生产业,2017,14(14):128-129. 被引量:2
二级引证文献32
-
1Xu-Hui Liu,Wen-Hao Qian.Effects of clopidogrel on coagulation function, antioxidant and related cytokines in patients with coronary heart disease[J].Journal of Hainan Medical University,2018,24(18):14-17.
-
2刘帅,赵艳茹,王红超.氯吡格雷在预防和治疗冠心病中的疗效及安全性研究[J].转化医学电子杂志,2015,2(4):84-84. 被引量:1
-
3张蕾,柴洪玲.冠心病治疗中波立维和泰嘉的临床治疗对比研究[J].当代医学,2016,22(5):142-143. 被引量:4
-
4王波,陈玉瑙,凌励.血小板抗体筛选及血小板交叉配型对血小板输注效果的影响[J].中外女性健康研究,2016(6):208-208. 被引量:5
-
5赵旭鸿,徐龙,韩平,华丽,蔡玉婵,李智.398例服用抗血小板药物患者血栓弹力图分析[J].检验医学,2016,31(6):513-515. 被引量:1
-
6李彬,王川.不同血小板计数方法结果比较及临床应用[J].海南医学院学报,2016,22(16):1877-1879. 被引量:2
-
7刘晓坤.氯吡格雷用于冠心病治疗的效果以及不良反应[J].当代医学,2016,22(24):142-143. 被引量:2
-
8张建新.氯吡格雷治疗老年冠心病的疗效及对PAG和凝血指标变化的影响[J].现代诊断与治疗,2016,27(16):3006-3007. 被引量:4
-
9于丽.氯吡格雷治疗冠心病患者的临床疗效及安全性评价[J].中国现代药物应用,2016,10(19):165-166. 被引量:6
-
10陶朝欣,邢江涛,张玉娜,柳江超,郭丽改,许丽亚,朱芸.意义未明的特发性血细胞减少症临床及实验室检测分析[J].检验医学,2016,31(11):929-935. 被引量:2
-
1张玲娣,鲁春晓,朱建军.浅谈抗血小板药物治疗监测方法[J].北方药学,2015,12(5):155-155. 被引量:1
-
2王利,孙新,赵海荣,张翠萍,徐修才.静脉采血的护理因素对老年患者血小板功能检测的影响[J].中国临床保健杂志,2008,11(4):430-431. 被引量:3
-
3继续教育园地[J].美国医学会杂志(中文版),2007,26(5):298-298.
-
4邹桂舟,李旭,余鑫之,程叶耕.重型病毒性肝炎患者血小板参数检测及其临床意义[J].安徽医科大学学报,1999,34(1):57-58. 被引量:2
-
5林英.彩色超声检查对脂肪肝的诊断价值[J].中国当代医药,2010,17(33):95-95. 被引量:3
-
6杨爱华,薛会光.肝硬化病人血小板4项参数的检测及意义[J].齐鲁医学杂志,2006,21(2):122-123. 被引量:4
-
7张真路,张李涛.正确认识血小板功能检测在急性冠状动脉综合征患者抗血小板治疗中的价值[J].中华检验医学杂志,2016,39(10):743-746. 被引量:3
-
8宋自阆,兰培相,张洪为.单采血小板的储存时间对其代谢功能影响的研究[J].国际输血及血液学杂志,2015,38(4):300-302. 被引量:1
-
9丛玉隆.国内凝血试验常规检查的热点话题与思考[J].中华检验医学杂志,2013,36(1):18-21. 被引量:8
-
10田然,曾勇.冠心病患者血小板功能检测的意义及应用前景[J].中华检验医学杂志,2013,36(6):489-493. 被引量:8